Impaired bone marrow B-cell development in mice with a bronchiolitis obliterans model of cGVHD.
Journal Article (Journal Article)
Chronic graft-versus-host disease (cGVHD) causes significant morbidity and mortality in patients after allogeneic bone marrow (BM) or stem cell transplantation (allo-SCT). Recent work has indicated that both T and B lymphocytes play an important role in the pathophysiology of cGVHD. Previously, our group showed a critical role for the germinal center response in the function of B cells using a bronchiolitis obliterans (BO) model of cGVHD. Here, we demonstrated for the first time that cGVHD is associated with severe defects in the generation of BM B lymphoid and uncommitted common lymphoid progenitor cells. We found an increase in the number of donor CD4+ T cells in the BM of mice with cGVHD that was negatively correlated with B-cell development and the frequency of osteoblasts and Prrx-1-expressing perivascular stromal cells, which are present in the B-cell niche. Use of anti-DR3 monoclonal antibodies to enhance the number of donor regulatory T cells (Tregs) in the donor T-cell inoculum ameliorated the pathology associated with BO in this model. This correlated with an increased number of endosteal osteoblastic cells and significantly improved the generation of B-cell precursors in the BM after allo-SCT. Our work indicates that donor Tregs play a critical role in preserving the generation of B-cell precursors in the BM after allo-SCT. Approaches to enhance the number and/or function of donor Tregs that do not enhance conventional T-cell activity may be important to decrease the incidence and severity of cGVHD in part through normal B-cell lymphopoiesis.
Full Text
- Published version (via Digital Object Identifier)
- Pubmed Central version
- Open Access Copy from Duke
- Link to Item
Duke Authors
Cited Authors
- Kolupaev, OV; Dant, TA; Bommiasamy, H; Bruce, DW; Fowler, KA; Tilley, SL; McKinnon, KP; Sarantopoulos, S; Blazar, BR; Coghill, JM; Serody, JS
Published Date
- September 25, 2018
Published In
- Blood Adv
Volume / Issue
- 2 / 18
Start / End Page
- 2307 - 2319
PubMed ID
- 30228128
Pubmed Central ID
- PMC6156893
Electronic International Standard Serial Number (EISSN)
- 2473-9537
Digital Object Identifier (DOI)
- 10.1182/bloodadvances.2017014977
Language
- eng
Conference Location
- United States